Overview

Buprenorphine Group Medical Visits in Primary Care

Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
0
Participant gender:
All
Summary
The primary goal of this research is to improve the effectiveness of buprenorphine maintenance treatment (BMT) within primary care. Investigators propose that providing BMT as part of a group medical visit (instead of an individual visit) will improve treatment outcomes for patients with persistent opioid abuse, because members become accountable to the group, are exposed to beneficial habits of others (i.e. positive deviance), and can receive efficacious behavioral interventions concomitantly with medical management
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Montefiore Medical Center
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine
Criteria
Inclusion Criteria:

1. Currently receiving BMT at Montefiore community health center (CHC).

2. Received BMT for 12 or more weeks.

3. Persistent opioid abuse (positive toxicology for an unprescribed opioid at most recent
test or in 50% or more of collected tests in the previous 6 months.)

4. Fluent in English of Spanish

Exclusion Criteria:

1) Pregnancy